Board Meeting30 March 2026 at 07:24 am
Medicamen Biotech Ltd. Announces Closure of Trading Window for Directors and Connected Persons
AI Summary
Medicamen Biotech Ltd. has announced the closure of the trading window for all Directors, Designated Persons, and Connected Persons under the Code from April 01, 2026. The closure will last till 48 hours after the declaration of Audited Financial Results for the quarter and year ended on March 31, 2026. This decision is in accordance with the provisions of the Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relatives. All Directors, Designated Persons, and Connected Persons under the Code have been advised not to trade in the securities of the Company during this period.
Key Highlights
- Medicamen Biotech Ltd. closes trading window for Directors, Designated Persons, and Connected Persons under the Code.
- Closure effective from April 01, 2026 till 48 hours after the declaration of Audited Financial Results for the year ended on March 31, 2026.
- Directed not to trade in the securities of the Company during the closure period.
- The decision is in accordance with the Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relatives.
- The date of the Board meeting to approve the Audited Financial Results will be intimated separately.
MEDICAMEQPharmaceuticals
MEDICAMEN BIOTECH LTD.-$Price Impact